dacarbazine and Breast Cancer

dacarbazine has been researched along with Breast Cancer in 74 studies

Research

Studies (74)

Timeframe	Studies, this research(%)	All Research%
pre-1990	11 (14.86)	18.7374
1990's	5 (6.76)	18.2507
2000's	29 (39.19)	29.6817
2010's	28 (37.84)	24.3611
2020's	1 (1.35)	2.80

Authors

Authors	Studies
Abrantes, AM; Botelho, MF; Gonçalves, AC; Laranjo, M; Rocha Gonsalves, AM; Sarmento-Ribeiro, AB; Serra, AC	1
Ayadi, M; Bahri, O; Berjeb, KK; Braham, M; Chakroun, N; Chtourou, S; Debbabi, L; Fadhlaoui, A; Hamdoun, M; Hannachi, H; Kacem, K; Zemni, Z; Zhioua, F	1
Luo, Y; Tang, J; Tian, J; Xiang, J	1
Askaa, J; Baggerly, KA; Coombes, KR; Knudsen, S; Mazin, W; Wang, W	1
Awada, A; Buttice, A; Cardoso, F; D'Hondt, V; de Azambuja, E; Devriendt, D; Gil, T; Lalami, Y; Lebrun, F; Lemort, M; Moulin, C; Paesmans, M; Piccart-Gebhart, M; Rossari, J; Sotiriou, C; Zardavas, D	1
Akbari, MR; Aldape, KD; Denton-Schneider, BR; Hicks, D; Lee, J; McMullin, RP; Moulis, S; Narod, SA; Ramaswamy, S; Sgroi, DC; Singavarapu, R; Steeg, PS; Wittner, BS; Yang, C	1
Biernat, W; Duchnowska, R; Gril, B; Hewitt, SM; Hua, E; Jassem, J; Liewehr, DJ; Palmieri, D; Qian, Y; Sosińska-Mielcarek, K; Stark, AM; Steeg, PS; Steinberg, SM; Woditschka, S	1
Bozzao, A; De Sanctis, V; Enrici, RM; Lanzetta, G; Minniti, G; Osti, M; Romano, A; Scaringi, C; Valeriani, M	1
Cao, KI; Kirova, YM	1
Benhammane, H; Bensouda, Y; Boutayeb, S; El Khannoussi, B; Elghissassi, I; Errihani, H; Kharmoum, J; Kharmoum, S; Mohamed, M; Mrabti, H; Sbitti, Y; Setti, K; Touri, S	1
Bourgier, C; Cao, KI; Gerber, S; Gobillion, A; Kirova, YM; Le Scodan, R; Lebas, N; Levy, C; Pierga, JY; Savignoni, A	1
Krishnamurthy, N; Liu, L; Montano, MM; Xiong, X; Zhang, J	1
Chen, J; Chen, X; Ji, M; Jin, J; Xu, B; Xue, N; Zhou, J; Zhou, Q	1
Diéras, V; Domchek, SM; Friedlander, M; Garber, JE; Giranda, VL; Han, HS; Isakoff, SJ; Johnson, EF; Kaufman, B; Maag, D; Puhalla, S; Qin, Q; Robson, M; Shepherd, SP; Telli, ML	1
Augustin, HG; Bae, J; Han, S; He, Y; Kim, C; Kim, I; Kim, IK; Kim, JH; Koh, GY; Lee, D; Lee, S; Oh, SJ; Park, I; Park, JS; Woo, DC	1
Hu, Z; Ma, W; Wang, Y; Yan, Y; Zhang, K; Zhao, P	1
Bontcheva-Diaz, V; Bouska, JJ; Donawho, CK; Frost, DJ; Fry, EH; Gandhi, VB; Giranda, VL; Gong, J; Grandel, R; Johnson, EF; Klinghofer, V; Liu, X; Lubisch, W; Luo, Y; Marsh, KC; Olson, AM; Park, CH; Penning, TD; Rosenberg, SH; Shi, Y; Thomas, S; Wernet, W; Zhu, GD	1
Addeo, R; Caraglia, M; Cennamo, G; De Rosa, C; Del Prete, S; Faiola, V; Guarrasi, R; Leo, L; Montella, L; Vincenzi, B	1
Jones, C; Plummer, ER	1
Alm El-Din, MA; El-Badawy, SA; Taghian, AG	1
Heppner, FL; Ingold, B; Moch, H; Schraml, P	1
Bajetta, E; Cascinu, S; Crinò, L; Danova, M; Del Prete, S; Salvagni, S; Schiavetto, I; Siena, S; Vitali, M	1
Buhk, JH; Hoffmann, AL; Strik, H	1
Doi, H; Iizuka, H; Ishida-Yamamto, A; Ito, Y; Tsuji, H	1
Bäuerle, T; Braun, K; Ehemann, V; Fleischhacker, H; Lorenz, P; Müller, G; Pipkorn, R; Waldeck, W; Wiessler, M	1
Guha, M	1
Belin, L; Bollet, MA; Campana, F; Decaudin, D; Fourquet, A; Haberer, S; Kirova, YM; Le Scodan, R; Moisson, P; Pierga, JY; Reyal, F; Savignoni, A; Stevens, D	1
Caviedes, I; Córdova, A; Delgado, IO; Goset, KC; Sánchez-Nieto, B	1
Tulin, A	1
Borden, EC; Budd, TG; Elson, P; Hollovary, E; Jacobs, B; Mitsuhashi, M; Spiro, T; Triozzi, P; Yi, T	1
Ivanov, VG; Korytova, LI; Masliukova, EA; Meshechkin, AV; Zhabuna, RM	1
Evens, A; Osborne, CK	1
Balañá, C; Bruna, J; Chacón, I; Gil, M; Langa, JM; Martín, M; Segura, PP	1
Kirova, Y; Tallet, A	1
Addeo, R; Caraglia, M; Carraturo, M; Cennamo, G; Iodice, P; Lombardi, A; Montella, L; Parlato, C; Prete, SD; Russo, P; Salzano, A; Sperlongano, P; Sperlongano, R; Vincenzi, B	1
Bardier, A; Blot, E; Decaudin, D; Pouillart, P; Veyradier, A; Zagame, OL	1
Isaacson, BJ; Islam, R; Ratanawong, C; Tipping, SJ; Zickerman, PM	1
Clemons, M; El Teraifi, H; Griffiths, A; Howell, A; Kelly, J; Margison, GP; Margison, JM; Morris, CQ; Ranson, M	1
Longo, DL	1
Komorowski, AL; Mituś, J; Wysocki, WM	1
Caldwell, D; Kelley, MR; Rinne, M	1
Ballardini, B; Bassi, F; De Pas, T; Gatti, G; Luini, A; Mauri, E	1
Aravantinos, G; Bafaloukos, D; Bamias, A; Carina, M; Christodoulou, C; Klouvas, G; Linardou, H; Skarlos, D	1
Narita, Y	1
Clemons, M; Howell, A; Kelly, J; Margison, GP; McElhinney, RS; McMurry, TB; Watson, AJ	1
Artemov, D; Kato, Y; Okollie, B	1
Bordeleau, L; Charpentier, D; Crump, M; Eisenhauer, E; Matthews, S; Trudeau, ME; Yelle, L	1
Abrey, LE; Demopoulos, A; Malkin, MG; Omuro, AM; Raizer, JJ	1
Baehring, J; Ballen, KK; Berliner, N; Henson, JW; Kracher, J; Lacy, J; Noronha, V	1
Arun, B; Broglio, K; Buchholz, T; Francis, D; Groves, M; Hortobagyi, GN; Meyers, C; Rivera, E; Valero, V; Yin, G	1
Ribatti, D	1
Weller, M	1
Balafouta, MJ; Kolokouris, D; Kouloulias, VE; Kouvaris, JR; Miliadou, A; Papacharalampous, XN; Vlahos, LJ	1
Cloud, GA; Fiveash, JB; Guthrie, BL; Markert, JM; Meredith, RF; Nordal, RA; Sawrie, SM; Spencer, SA	1
Chesnutt, DA; Cummings, TJ; Heimann, A; Morris, CL; Mukundan, S	1
Alvino, E; Bonmassar, E; Caporali, S; D'Atri, S; Levati, L; Ragone, G; Starace, G	1
Kemeny, N	1
Falkson, G; Falkson, HC	1
Wełnicka-Jaśkiewicz, M; Zaucha, R	1
Dugan, M; Gerson, SL; Izbicka, E; Raymond, E; Soda, H; Von Hoff, DD	1
Berger, D; Bonfanti, M; D'Incalci, M; Fiebig, HH; Mascellani, E; Pifferi, A; Tagliabue, G	1
Calvert, AH; Curtin, NJ; Delaney, CA; Durkacz, BW; Hostomsky, Z; Kyle, S; Newell, DR; Wang, LZ; White, AW	1
Sauter, C	1
Blumenschein, GR; Buzdar, AU; Krutchik, AN; Sinkovics, JG	1
Cruz, AB; Davis, HL; Fletcher, WS; Golomb, FM; Grage, T; Hill, GJ; Johnson, RO; Metter, G; Wilson, WL	1
Gutterman, JU; Hersh, EM; Mavligit, GM	1
Blumenshein, G; Burgess, MA; Gutterman, JU; Hersh, EM; Mavligit, GM; McBride, CM	1
Agnifili, A; Carboni, M; D'Amore, L; Gianfelice, F; Giuliani, M; Gossetti, F; Negro, P	1
Blackledge, GR; Brampton, MH; Hoffman, R; Newlands, ES; Quarterman, CP; Rustin, GJ; Slack, JA; Smith, DB; Stevens, MF; Stuart, NS	1
Jestrimski, KW; Lowenthal, RM	1
Biran, S; Sulkes, A; Yahalom, J	1
Schoen, HD; Wendt, T	1
Haga, S; Hirayama, A; Imamura, H; Sakakibara, N	1
Borovik, R; Cohen, Y; Haim, N; Kuten, A; Robinson, E; Sapir, D	1

Reviews

8 review(s) available for dacarbazine and Breast Cancer

Article	Year
Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis. Journal of neuro-oncology, 2017, Volume: 135, Issue:2 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dacarbazine; Humans; Lung Neoplasms; Randomized Controlled Trials as Topic; Temozolomide	2017
[Radiotherapy plus concomitant systemic therapies for patients with brain metastases from breast cancer]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:3 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Dacarbazine; Deoxycytidine; Female; Fluorouracil; Humans; Lapatinib; Protein Kinase Inhibitors; Quinazolines; Radiotherapy, Adjuvant; Receptor, ErbB-2; Temozolomide; Thalidomide; Topoisomerase I Inhibitors; Topotecan; Trastuzumab; Vinblastine; Vinorelbine	2014
Breast cancer after treatment of Hodgkin's lymphoma: general review. International journal of radiation oncology, biology, physics, 2008, Dec-01, Volume: 72, Issue:5 Topics: Adolescent; Adult; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Child; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Radionuclide Imaging; Radiotherapy; Risk Factors; Splenectomy; Vinblastine; Vincristine; Young Adult	2008
[Brain metastases from breast cancer: prognostic factors and tailored management]. Bulletin du cancer, 2013, Jan-01, Volume: 100, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Dacarbazine; Female; Humans; Prognosis; Radiation-Sensitizing Agents; Randomized Controlled Trials as Topic; Temozolomide	2013
[Chemotherapy for brain metastases]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 9 Topics: Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Dacarbazine; Dementia, Vascular; Humans; Lung Neoplasms; Melanoma; Metalloporphyrins; Prednisolone; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Temozolomide	2005
Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literature. Neuro-oncology, 2006, Volume: 8, Issue:3 Topics: Aged; Breast Neoplasms; Dacarbazine; Female; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms, Second Primary; Oligodendroglioma; Temozolomide	2006
The systemic chemotherapy of hepatic metastases. Seminars in oncology, 1983, Volume: 10, Issue:2 Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; Drug Therapy, Combination; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Pancreatic Neoplasms; Rectal Neoplasms; Semustine; Stomach Neoplasms	1983
Corticosteroid drugs: their role in oncological practice. The Medical journal of Australia, 1986, Jan-20, Volume: 144, Issue:2 Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Dyspnea; Fluorouracil; Hodgkin Disease; Humans; Hypercalcemia; Leukemia; Leukemia, Lymphoid; Lymphoma; Mechlorethamine; Melphalan; Methotrexate; Multiple Myeloma; Palliative Care; Prednisone; Procarbazine; Receptors, Glucocorticoid; Vinblastine; Vincristine; Vomiting	1986

Trials

15 trial(s) available for dacarbazine and Breast Cancer

Article	Year
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Dacarbazine; Disease-Free Survival; Female; Humans; Lapatinib; Maximum Tolerated Dose; Middle Aged; Quinazolines; Receptor, ErbB-2; Temozolomide; Treatment Outcome	2013
Whole brain reirradiation and concurrent temozolomide in patients with brain metastases. Journal of neuro-oncology, 2014, Volume: 118, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cranial Irradiation; Dacarbazine; Disease Progression; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Retreatment; Retrospective Studies; Temozolomide; Treatment Outcome	2014
Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Disease-Free Survival; Female; Humans; Middle Aged; Prospective Studies; Temozolomide	2015
A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale. Future oncology (London, England), 2017, Volume: 13, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Carboplatin; Clinical Protocols; Dacarbazine; Drug Monitoring; Female; Humans; Models, Statistical; Paclitaxel; Research Design; Sample Size; Temozolomide	2017
Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases. Cancer, 2008, Nov-01, Volume: 113, Issue:9 Topics: Aged; Antineoplastic Agents, Alkylating; Bone Marrow; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Prognosis; Remission Induction; Survival Rate; Temozolomide	2008
Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:3 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Dacarbazine; Drug Resistance, Neoplasm; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Prospective Studies; Remission Induction; Salvage Therapy; Survival Rate; Temozolomide; Treatment Outcome	2010
Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects. Oncotarget, 2011, Volume: 2, Issue:12 Topics: Adult; Aged; Antimony Sodium Gluconate; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Colorectal Neoplasms; Dacarbazine; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastrointestinal Stromal Tumors; Humans; Interferon alpha-2; Interferon-alpha; Male; Melanoma; Middle Aged; Phosphoric Monoester Hydrolases; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Recombinant Proteins; Sarcoma; Vinblastine	2011
Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors. Journal of neuro-oncology, 2012, Volume: 109, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Dacarbazine; Female; Follow-Up Studies; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Meningeal Neoplasms; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Survival Rate; Temozolomide	2012
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study. Journal of neuro-oncology, 2005, Volume: 71, Issue:1 Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cisplatin; Dacarbazine; Female; Humans; Leukopenia; Lung Neoplasms; Male; Melanoma; Middle Aged; Nausea; Stomach Neoplasms; Temozolomide; Treatment Outcome	2005
Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG). Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:6 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Breast Neoplasms; Dacarbazine; Disease Progression; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Metastasis; Patient Selection; Temozolomide; Treatment Outcome	2006
Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial. Journal of neuro-oncology, 2006, Volume: 78, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Lymphopenia; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Temozolomide; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine	2006
Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer, 2006, Sep-15, Volume: 107, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Capecitabine; Cohort Studies; Dacarbazine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Humans; Middle Aged; Nausea; Temozolomide; Treatment Outcome; Vomiting	2006
Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors. Onkologie, 2007, Volume: 30, Issue:7 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Female; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Mouth Neoplasms; Neoplasms, Unknown Primary; Palliative Care; Rectal Neoplasms; Research Design; Temozolomide; Treatment Outcome	2007
The systemic chemotherapy of hepatic metastases. Seminars in oncology, 1983, Volume: 10, Issue:2 Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; Drug Therapy, Combination; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Pancreatic Neoplasms; Rectal Neoplasms; Semustine; Stomach Neoplasms	1983
Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). British journal of cancer, 1992, Volume: 65, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Colorectal Neoplasms; Dacarbazine; Drug Administration Schedule; Drug Evaluation; Female; Glioma; Humans; Kidney Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Stomach Neoplasms; Temozolomide	1992

Other Studies

52 other study(ies) available for dacarbazine and Breast Cancer

Article	Year
Synthesis of new 2-galactosylthiazolidine-4-carboxylic acid amides. Antitumor evaluation against melanoma and breast cancer cells. European journal of medicinal chemistry, 2012, Volume: 53 Topics: Antineoplastic Agents; Breast Neoplasms; Carboxylic Acids; Cell Line, Tumor; Cell Survival; Chemistry Techniques, Synthetic; Dose-Response Relationship, Drug; Humans; Melanoma	2012
Evaluation of ovarian reserve before and after chemotherapy. Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:5 Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Female; Fertility Preservation; Fluorouracil; Hodgkin Disease; Humans; Longitudinal Studies; Luminescent Measurements; Ovarian Reserve; Prednisone; Procarbazine; Vinblastine; Vincristine; Young Adult	2021
Independent validation of a model using cell line chemosensitivity to predict response to therapy. Journal of the National Cancer Institute, 2013, Sep-04, Volume: 105, Issue:17 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Breast Neoplasms; Cell Line, Tumor; Dacarbazine; Doxorubicin; Epirubicin; Female; Gene Expression Regulation, Neoplastic; Hodgkin Disease; Humans; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; ROC Curve; Treatment Outcome; Vinblastine	2013
A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity. Breast cancer research : BCR, 2014, Mar-14, Volume: 16, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; BRCA1 Protein; Breast Neoplasms; Cell Line; Cell Line, Tumor; Dacarbazine; DNA Damage; DNA Mutational Analysis; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Oligonucleotide Array Sequence Analysis; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Prognosis; Receptor, ErbB-2; Temozolomide; Transcriptome	2014
Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, May-15, Volume: 20, Issue:10 Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; MCF-7 Cells; Mice; Mice, Nude; RNA Interference; Temozolomide; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays	2014
Conjonctival melanoma metastatic to the breast: a case report. BMC research notes, 2014, Sep-09, Volume: 7 Topics: Adult; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Conjunctival Neoplasms; Dacarbazine; Drug Administration Schedule; Fatal Outcome; Female; Humans; Immunohistochemistry; Melanoma; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Palliative Care; Time Factors; Treatment Outcome	2014
Downregulation of hPMC2 imparts chemotherapeutic sensitivity to alkylating agents in breast cancer cells. Cancer biology & therapy, 2015, Volume: 16, Issue:4 Topics: Alkylating Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dacarbazine; DNA Breaks, Double-Stranded; DNA Repair; Down-Regulation; Exonucleases; Female; Histones; Humans; Temozolomide	2015
Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer. Biochemical pharmacology, 2016, May-01, Volume: 107 Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Drug Agonism; Drug Design; Female; G2 Phase; Humans; Mice, Nude; Organosilicon Compounds; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinazolinones; Recombinant Proteins; Temozolomide; Triple Negative Breast Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays	2016
Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment. Cancer cell, 2016, Dec-12, Volume: 30, Issue:6 Topics: Animals; Antibodies; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Lewis Lung; Dacarbazine; Drug Synergism; Female; Glioma; Humans; Mice; Neoplasm Transplantation; Protein Binding; Receptor, TIE-2; Ribonuclease, Pancreatic; Temozolomide; Treatment Outcome; Tumor Microenvironment	2016
BMI-1 Promotes Self-Renewal of Radio- and Temozolomide (TMZ)-Resistant Breast Cancer Cells. Reproductive sciences (Thousand Oaks, Calif.), 2017, Volume: 24, Issue:12 Topics: Animals; Antineoplastic Agents, Alkylating; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Self Renewal; Combined Modality Therapy; Dacarbazine; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Mice, SCID; Polycomb Repressive Complex 1; Temozolomide; Xenograft Model Antitumor Assays	2017
Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorganic & medicinal chemistry, 2008, Jul-15, Volume: 16, Issue:14 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Breast Neoplasms; Cisplatin; Dacarbazine; Enzyme Inhibitors; Humans; Melanoma, Experimental; Mice; Poly(ADP-ribose) Polymerase Inhibitors; Structure-Activity Relationship; Temozolomide; Transplantation, Heterologous; Xenograft Model Antitumor Assays	2008
PARP inhibitors and cancer therapy - early results and potential applications. The British journal of radiology, 2008, Volume: 81 Spec No 1 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Breast Neoplasms; Dacarbazine; Enzyme Inhibitors; Female; Humans; Melanoma; Mice; Ovarian Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Temozolomide	2008
Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors. PloS one, 2009, Volume: 4, Issue:3 Topics: Alkylating Agents; Brain Neoplasms; Breast Neoplasms; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Immunohistochemistry; Kidney Neoplasms; Lung Neoplasms; Melanoma; Polymerase Chain Reaction; Promoter Regions, Genetic; Temozolomide; Tumor Suppressor Proteins	2009
Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C combined with dose-dense temozolomide. Anticancer research, 2009, Volume: 29, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Dacarbazine; Feasibility Studies; Female; Humans; Injections, Spinal; Liposomes; Meningeal Neoplasms; Temozolomide	2009
Malignant melanoma of the breast: N-isopropyl-p-(123) I-iodoamphetamine single photon emission computed tomography ((123) I-IMP SPECT) is useful for the detection of metastasis. The Journal of dermatology, 2010, Volume: 37, Issue:9 Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cisplatin; Dacarbazine; Fatal Outcome; Female; Humans; Interferon-beta; Iofetamine; Liver Neoplasms; Lung Neoplasms; MART-1 Antigen; Mastectomy, Modified Radical; Melanoma; Middle Aged; Neoplasm Staging; Nimustine; Nipples; Radiopharmaceuticals; S100 Proteins; Skin Neoplasms; Tamoxifen; Tomography, Emission-Computed, Single-Photon; Vincristine	2010
A cyclic-RGD-BioShuttle functionalized with TMZ by DARinv "Click Chemistry" targeted to αvβ3 integrin for therapy. International journal of medical sciences, 2010, Sep-21, Volume: 7, Issue:6 Topics: Antineoplastic Agents, Alkylating; Breast Neoplasms; Cell Line, Tumor; Cell Size; Dacarbazine; Female; Flow Cytometry; HeLa Cells; Humans; Inhibitory Concentration 50; Integrin alphaVbeta3; Microscopy, Confocal; Peptides, Cyclic; Temozolomide; Uterine Cervical Neoplasms	2010
PARP inhibitors stumble in breast cancer. Nature biotechnology, 2011, Volume: 29, Issue:5 Topics: Alleles; Antineoplastic Agents, Alkylating; Breast Neoplasms; Clinical Trials as Topic; Dacarbazine; DNA Damage; DNA Repair; Enzyme Inhibitors; Female; Genes, BRCA1; Genes, BRCA2; Humans; Poly(ADP-ribose) Polymerase Inhibitors; Temozolomide	2011
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option. International journal of radiation oncology, biology, physics, 2012, Feb-01, Volume: 82, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Combined Modality Therapy; Confidence Intervals; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymph Node Excision; Mastectomy, Segmental; Mechlorethamine; Mediastinum; Middle Aged; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Young Adult	2012
Predictive models for pulmonary function changes after radiotherapy for breast cancer and lymphoma. International journal of radiation oncology, biology, physics, 2012, Feb-01, Volume: 82, Issue:2 Topics: Adolescent; Adult; Age Factors; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Lung; Lymphoma; Male; Middle Aged; Models, Biological; Multivariate Analysis; Organs at Risk; Prednisone; Prospective Studies; Pulmonary Diffusing Capacity; Radiation Injuries; Radiotherapy Dosage; Respiratory Function Tests; Smoking; Spirometry; Vinblastine; Vincristine; Young Adult	2012
Re-evaluating PARP1 inhibitor in cancer. Nature biotechnology, 2011, Dec-08, Volume: 29, Issue:12 Topics: Antineoplastic Agents, Alkylating; Breast Neoplasms; Dacarbazine; Enzyme Inhibitors; Female; Humans; Poly(ADP-ribose) Polymerase Inhibitors	2011
[Brain metastasis in breast cancer]. Voprosy onkologii, 2011, Volume: 57, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Chemoradiotherapy; Dacarbazine; Dexamethasone; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Humans; Karnofsky Performance Status; Lomustine; Middle Aged; Retrospective Studies; Survival Analysis; Temozolomide; Treatment Outcome; Vincristine	2011
Select interviews from the 2011 San Antonio Breast Cancer Symposium (SABCS) and American Society of Hematology (ASH) Annual Meeting. Oncology (Williston Park, N.Y.), 2011, Volume: 25, Issue:14 Topics: Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fertility Preservation; Humans; Lapatinib; Lymphoma; Molecular Targeted Therapy; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Quinazolines; Receptor, ErbB-2; Rituximab; Trastuzumab; Vinblastine; Vincristine	2011
Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases. Cancer chemotherapy and pharmacology, 2012, Volume: 70, Issue:4 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Female; Humans; Middle Aged; Quality of Life; Temozolomide; Vinblastine; Vinorelbine	2012
Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency. Thrombosis research, 2002, Apr-15, Volume: 106, Issue:2 Topics: ADAM Proteins; ADAMTS13 Protein; Adenocarcinoma; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; CA-19-9 Antigen; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Esophageal Neoplasms; Fatal Outcome; Female; Humans; Ifosfamide; Jaundice; Metalloendopeptidases; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Paraneoplastic Syndromes; Sarcoma; Thrombocytopenia; von Willebrand Factor	2002
Hemorrhagic cystitis as an unexpected adverse reaction to temozolomide: case report. American journal of clinical oncology, 2002, Volume: 25, Issue:5 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms; Cystitis; Dacarbazine; Female; Hemorrhage; Humans; Middle Aged; Temozolomide	2002
Pharmacokinetic, biochemical and clinical effects of dimethyltriazenoimidazole-4-carboxamide-bischloroethylnitrosourea combination therapy in patients with advanced breast cancer. International journal of cancer, 2003, Feb-20, Volume: 103, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biopsy, Needle; Breast Neoplasms; Carmustine; Dacarbazine; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Immunoenzyme Techniques; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase	2003
Radiation therapy in the treatment of Hodgkin's disease--do you see what I see? Journal of the National Cancer Institute, 2003, Jul-02, Volume: 95, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Incidence; Mechlorethamine; Menopause, Premature; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Vinblastine; Vincristine	2003
Synchronous cancer and metastatic melanoma of the breasts. Archives of gynecology and obstetrics, 2004, Volume: 270, Issue:4 Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplatin; Dacarbazine; Female; Humans; Mammography; Melanoma; Retroperitoneal Neoplasms; Tamoxifen	2004
Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells. Molecular cancer therapeutics, 2004, Volume: 3, Issue:8 Topics: Adenoviridae; Alkylating Agents; Antineoplastic Agents, Alkylating; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Comet Assay; Dacarbazine; DNA Glycosylases; DNA Repair; Dose-Response Relationship, Drug; Genetic Therapy; Genetic Vectors; Humans; Hydroxylamines; Immunohistochemistry; Methyl Methanesulfonate; Methylnitronitrosoguanidine; Methylnitrosourea; Oligonucleotides; Sensitivity and Specificity; Sulfuric Acid Esters; Temozolomide; Time Factors	2004
Breast metastases from cutaneous malignant melanoma. Breast (Edinburgh, Scotland), 2004, Volume: 13, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Female; Humans; Melanoma; Middle Aged; Skin Neoplasms; Vincristine	2004
O6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts. British journal of cancer, 2005, Nov-14, Volume: 93, Issue:10 Topics: Animals; Body Weight; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Resistance, Neoplasm; Guanine; Humans; Male; Mice; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide; Xenograft Model Antitumor Assays	2005
Noninvasive 1H/13C magnetic resonance spectroscopic imaging of the intratumoral distribution of temozolomide. Magnetic resonance in medicine, 2006, Volume: 55, Issue:4 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Breast Neoplasms; Carbon Isotopes; Contrast Media; Dacarbazine; Feasibility Studies; Female; Gadolinium DTPA; Imaging, Three-Dimensional; Magnetic Resonance Spectroscopy; Mice; Mice, SCID; Phantoms, Imaging; Temozolomide	2006
The contribution of Gianni Bonadonna to the history of chemotherapy. Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cisplatin; Dacarbazine; Doxorubicin; Female; Fluorouracil; History, 20th Century; Hodgkin Disease; Humans; Italy; Methotrexate; Neoplasms; Vinblastine	2007
Radiochemotherapy for brain metastasis: how to define a role for temozolomide. Onkologie, 2007, Volume: 30, Issue:7 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Cranial Irradiation; Dacarbazine; Humans; Lung Neoplasms; Melanoma; Mouth Neoplasms; Neoplasms, Unknown Primary; Rectal Neoplasms; Research Design; Temozolomide; Treatment Outcome	2007
Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. International journal of radiation oncology, biology, physics, 2008, Jan-01, Volume: 70, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Dacarbazine; Female; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Radiosurgery; Retrospective Studies; Temozolomide	2008
Stage IV primitive-appearing sinus and orbital rhabdomyosarcoma presenting in a 68-year-old female previously treated for breast cancer. Orbit (Amsterdam, Netherlands), 2008, Volume: 27, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Maxillary Sinus Neoplasms; Mesna; Orbital Neoplasms; Rhabdomyosarcoma	2008
AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition. Molecular pharmacology, 2008, Volume: 74, Issue:1 Topics: Antineoplastic Agents, Alkylating; Ataxia Telangiectasia Mutated Proteins; B-Lymphocytes; Breast Neoplasms; Carcinoma; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Female; HCT116 Cells; Humans; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Temozolomide	2008
A five-drug combination in the treatment of metastatic breast cancer. Cancer clinical trials, 1981, Volume: 4, Issue:1 Topics: Antineoplastic Agents; Breast Neoplasms; Carmustine; Dacarbazine; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Prednisone	1981
[Hemangioblastoma of the breast]. Polskie Archiwum Medycyny Wewnetrznej, 1996, Volume: 95, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hemangioblastoma; Humans; Radiotherapy Dosage; Remission Induction; Vincristine	1996
Activity of temozolomide against human tumor colony-forming units. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10 Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms; Cell Division; Dacarbazine; Digestive System Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Hematologic Neoplasms; Humans; Lung Neoplasms; Neoplasm Proteins; Neoplastic Stem Cells; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urogenital Neoplasms	1997
The antitumour activity of alkylating agents is not correlated with the levels of glutathione, glutathione transferase and O6-alkylguanine-DNA-alkyltransferase of human tumour xenografts. EORTC SPG and PAMM Groups. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:11 Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Dacarbazine; Glutathione; Glutathione Transferase; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms; Nitrosourea Compounds; Stomach Neoplasms; Transplantation, Heterologous	1998
Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:7 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Survival; Colonic Neoplasms; Dacarbazine; Drug Synergism; Enzyme Inhibitors; Female; Humans; Lung Neoplasms; Ovarian Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Temozolomide; Topotecan; Tumor Cells, Cultured; Tumor Stem Cell Assay	2000
[Diagnostic problems due to alternative medicine]. Schweizerische medizinische Wochenschrift, 2000, Jul-25, Volume: 130, Issue:29-30 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Dacarbazine; Diagnosis, Differential; Doxorubicin; Female; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Radiography; Skin; Tamoxifen; Vinblastine; Vincristine	2000
Amphotericin B and combination chemotherapy in the treatment of refractory metastatic breast carcinoma and sarcoma. Cancer treatment reports, 1978, Volume: 62, Issue:10 Topics: Adult; Aged; Amphotericin B; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Sarcoma; Vincristine	1978
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.? Surgery, gynecology & obstetrics, 1976, Volume: 142, Issue:6 Topics: Adult; Altretamine; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carmustine; Colonic Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lomustine; Lung Neoplasms; Male; Melanoma; Mitolactol; Neoplasms; Osteosarcoma; Pancreatic Neoplasms; Rectal Neoplasms; Vincristine	1976
Chemoimmunotherapy of human solid tumors. The Medical clinics of North America, 1976, Volume: 60, Issue:3 Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Colonic Neoplasms; Dacarbazine; Drug Therapy, Combination; Humans; Immunization Schedule; Immunotherapy; Lung Neoplasms; Lymphatic Metastasis; Lymphoma; Melanoma; Neoplasms; Neoplasms, Experimental; Osteosarcoma	1976
Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer. Annals of the New York Academy of Sciences, 1976, Volume: 277, Issue:00 Topics: BCG Vaccine; Breast Neoplasms; Colonic Neoplasms; Dacarbazine; Doxorubicin; Female; Fluorouracil; Humans; Immunotherapy; Melanoma; Neoplasm Metastasis; Rectal Neoplasms; Time Factors	1976
[Breast metastases of skin melanoma]. Il Giornale di chirurgia, 1990, Volume: 11, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Dacarbazine; Female; Humans; Interferons; Male; Melanoma; Skin; Skin Neoplasms	1990
[Treatment of metastatic breast cancer]. Harefuah, 1986, Volume: 111, Issue:1-2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Prednisone; Random Allocation; Vinblastine; Vincristine	1986
[The effect of chemotherapy on survival time in advanced breast carcinoma]. Deutsche medizinische Wochenschrift (1946), 1989, Jun-16, Volume: 114, Issue:24 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Female; Fluorouracil; Humans; Neoplasm Metastasis; Postoperative Care; Prednisone; Retrospective Studies; Time Factors; Vincristine	1989
[A case of metastatic breast tumors due to extraskeletal Ewing's sarcoma]. Nihon Geka Gakkai zasshi, 1986, Volume: 87, Issue:10 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Pelvic Neoplasms; Sarcoma, Ewing; Vincristine	1986
Postirradiation soft tissue sarcoma occurring in breast cancer patients: report of seven cases and results of combination chemotherapy. Journal of surgical oncology, 1985, Volume: 28, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Middle Aged; Neoplasms, Radiation-Induced; Radiotherapy; Sarcoma; Soft Tissue Neoplasms; Vincristine	1985